Concomitant lithium increases radioiodine uptake and absorbed doses per administered activity in graves’ disease: comparison of conventional versus lithium-augmented radioiodine therapy

Concomitant lithium increases radioiodine uptake and absorbed doses per administered activity in graves’ disease: comparison of conventional versus lithium-augmented radioiodine therapy

BackgroundLithium inhibits iodine and thyroid hormone release from thyroid cells, possibly increasing radioiodine retention and anti-hyperthyroid efficacy when given adjunctively to radioiodine therapy (RAI) of Graves’ disease (GD). However, the literature contains limited dosimetric data regarding...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Fadi Khreish, Andrea Schaefer-Schuler, Leonie Roth, Caroline Burgard, Florian Rosar, Samer Ezziddin
Formaat: Artikel
Taal:English
Gepubliceerd in: Frontiers Media S.A. 2024-04-01
Reeks:Frontiers in Medicine
Onderwerpen:
Graves’ disease
radioiodine therapy
lithium
dosimetry
administered activity
thyroidal radioiodine uptake
Online toegang:https://www.frontiersin.org/articles/10.3389/fmed.2024.1382024/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2024.1382024/full

Gelijkaardige items